Healthcare supply chains face a reality they weren’t originally designed for: disruptions that emerge faster, reach deeper into supplier networks, and directly impact patient care. From ongoing drug shortages to climate and geopolitical disruptions, supply chain risk has evolved from occasional events into a constant, interconnected challenge, one that often stays hidden until it’s already causing problems.
That’s why Resilinc is excited to partner with the Healthcare Industry Resilience Collaborative (HIRC) to help healthcare organizations move from static standards to operational, day-to-day resilience.
Announced this week, the Resilinc–HIRC partnership combines HIRC’s industry-led standards and collaborative frameworks with Resilinc’s AI-powered supply chain risk and compliance intelligence. The mission: help healthcare organizations detect risks earlier, focus on what matters most, and respond faster to protect continuity of care.
From guidelines to daily operations
Healthcare organizations have long used standards, assessments, and periodic mapping exercises to manage supply chain risk. While valuable, these approaches struggle to keep pace with an environment where disruptions start upstream, evolve quickly, and ripple across multiple supplier tiers.
This partnership shifts that dynamic.
Together, HIRC and Resilinc are making resilience operational, a continuous capability rather than a quarterly exercise. By integrating trusted industry standards into real-time risk monitoring, multi-tier visibility, and coordinated response workflows, organizations can move from reactive triage to proactive, system-level preparedness.
Resilinc’s agentic AI platform continuously harmonizes supplier, material flow, and regulatory data into a live, multi-tier supply chain map. Agentic AI monitors for disruptions and compliance risks, prioritizes them based on business and patient impact, and coordinates mitigation actions across teams and partners, all with human oversight built into the process.
Why it matters now
The numbers tell the story. According to Resilinc’s life sciences analysis, only 11% of manufacturers producing active pharmaceutical ingredients (APIs) for FDA-approved products are based in the United States. That leaves healthcare supply chains heavily exposed to upstream disruptions and geopolitical volatility. Meanwhile, cyber incidents, factory disruptions, and compliance issues continue to rise, often originating beyond direct suppliers.
In this environment, supply chain health isn’t about collecting more alerts or more data. It’s about connecting insight to action faster and more consistently than disruptions can spread.
A shared commitment to patient care
As HIRC Executive Director Jesse Schafer noted, the partnership enables shared standards to deliver “meaningful, real-world value” for HIRC members, helping them understand and manage risk at the tier-n level, not just at their immediate supplier relationships.
For Resilinc, this partnership reinforces something we’ve seen repeatedly: healthcare supply chains rarely fail all at once. They fail when small, upstream risks go unnoticed. By working with HIRC, we’re helping change that pattern, turning resilience from concept into practice.
What’s next
As part of the collaboration, Resilinc and HIRC will launch a Healthcare Supply Chain Resilience Series focused on real-world disruption scenarios, applied risk sensing strategies, and practical approaches for strengthening resilience across healthcare networks. We’ll share details soon.
Together, HIRC and Resilinc are helping the healthcare ecosystem move beyond static snapshots and reactive triage, toward a future where risk is monitored continuously, responses are prioritized intelligently, and patient care is protected through collaboration, clarity, and speed.
Read the press release for more information.
